X-bunden trombocytopeni med talassemi i två svenska familjer

Lakartidningen

Volumn 109, Issue 34-35, 2012, Pages 1474-1477

  Danielsson, Signe ^a   Merup, Mats ^b   Olsson, Lovisa ^a   Palmblad, Jan ^a,c   Åström, Maria ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GATA1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR GATA 1;

ADULT; ARTICLE; BONE MARROW; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MYELOID METAPLASIA; PATHOLOGY; PEDIGREE; SPLENOMEGALY; SWEDEN; THALASSEMIA; THROMBOCYTOPENIA; X CHROMOSOME LINKED DISORDER;

ADULT; BONE MARROW; DIAGNOSIS, DIFFERENTIAL; FEMALE; GATA1 TRANSCRIPTION FACTOR; GENETIC DISEASES, X-LINKED; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PRIMARY MYELOFIBROSIS; SPLENOMEGALY; SWEDEN; THALASSEMIA; THROMBOCYTOPENIA;

EID: 84866519562     PISSN: 00237205     EISSN: 16527518     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Balduini CL, Cattaneo M, Fabris F, et al. Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica. 2003;88:582-92.
2. Bolton-Maggs PH, Chalmers EA, Collins PW, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol. 2006;135:603-33.
3. Ciovacco WA, Raskind WH, Kacena MA. Human phenotypes associated with GATA-1 mutations. Gene. 2008;427:1-6.
4. Thompson AR, Wood WG, Stamatoyannopoulos G. X-linked syndrome of platelet dysfunction, thrombocytopenia, and imbalanced globin chain synthesis with hemolysis. Blood. 1977;50:303-16.
5. Raskind WH, Niakan KK, Wolff J, et al. Mapping of a syndrome of X-linked thrombocytopenia with Thalassemia to band Xp11-12: further evidence of genetic heterogeneity of X-linked thrombocytopenia. Blood. 2000;95:2262-8.
6. Yu C, Niakan KK, Matsushita M, et al. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood. 2002; 100:2040-5
7. Balduini CL, Pecci A, Loffredo G, et al. Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis. Thromb Haemost. 2004;91:129-40.
8. Hughan SC, Senis Y, Best D, et al. Selective impairment of platelet activation to collagen in the absence of GATA1. Blood. 2005;105: 4369-76.
9. Tubman VN, Levine JE, Campagna DR, et al. X-linked gray platelet syndrome due to a GATA1 Arg-216Gln mutation. Blood. 2007;109: 3297-9.
10. Thiele J, Kvasnicka HM, Facchetti F, et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 2005;90:1128-32.
11. Merup M, Palmblad J. Myelofibros i ny belysning. Ny klassifikation introducerad, nya behandlingsprinciper på väg. Läkartidningen. 2009;106:3342, 3344-6.
12. White JG, Thomas A. Platelet structural pathology in a patient with the X-linked GATA-1, R216Q mutation. Platelets. 2009;20:41-9.
13. Nurden AT, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev. 2007;21:21-36.
14. Balduini CL, De Candia E, Savoia A. Why the disorder induced by GATA1 Arg216Gln mutation should be called »X-linked thrombocytopenia with thalassemia« rather than »X-linked gray platelet syndrome«. Blood. 2007;110: 2770-1.